Clinical trial
A Pilot Study of Terazosin for Parkinson's Disease
NCT03905811 is registered in ClinicalTrials.gov with Jordan Schultz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Terazosin for Parkinson's Disease
- Lead sponsor
- Jordan Schultz
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 24, 2019
- Completion date
- November 18, 2020
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.